Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.
2.
3.

Clinical implications of fluorescence in situ hybridization analysis in 13 chronic myeloid leukemia cases: Ph-negative and variant Ph-positive.

Yehuda O, Abeliovich D, Ben-Neriah S, Sverdlin I, Cohen R, Varadi G, Orr R, Ashkenazi YJ, Heyd J, Lugassy G, Ben Yehuda D.

Cancer Genet Cytogenet. 1999 Oct 15;114(2):100-7.

PMID:
10549264
4.

Characterization of a complex translocation [t(4;9;22)(p16;q34;q11)] in chronic myelogenous leukemia by fluorescence in situ hybridization technique.

Gudi R, Elizalde A, Gogineni SK, Macera MJ, Badillo A, Verma RS.

Cancer Genet Cytogenet. 1996 Sep;90(2):142-5. Review.

PMID:
8830724
5.
6.

Complex variant Philadelphia translocations involving the short arm of chromosome 6 in chronic myeloid leukemia.

La Starza R, Testoni N, Lafage-Pochitaloff M, Ruggeri D, Ottaviani E, Perla G, Martelli MF, Marynen P, Mecucci C.

Haematologica. 2002 Feb;87(2):143-7.

7.

Chronic myeloid leukemia with a rare variant Philadelphia translocation: t(9;22;21)(q34;q11;q22).

Guillaume B, Ameye G, Libouton JM, Dierlamm J, Vaerman JL, Straetmans N, Ferrant A, Verellen-Dumoulin C, Michaux L.

Cancer Genet Cytogenet. 2000 Jan 15;116(2):166-9.

PMID:
10640151
9.

Complex variant Philadelphia translocation involving the short arm of chromosome 9 in a case of chronic myeloid leukemia.

Cianciulli AM, Marzano R, Merola R, Orlandi G, Petti MC, Guadagni F, Pisani F.

Haematologica. 2004 Sep;89(9):ECR37.

10.
11.

Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.

Bennour A, Sennana H, Laatiri MA, Elloumi M, Khelif A, Saad A.

Cancer Genet Cytogenet. 2009 Oct;194(1):30-7. doi: 10.1016/j.cancergencyto.2009.05.010.

PMID:
19737651
12.

A Philadelphia chromosome positive CML patient with a unique translocation studied via GTG-banding and fluorescence in situ hybridization.

Young C, Di Benedetto J Jr, Glasser L, Mark HF.

Cancer Genet Cytogenet. 1996 Jul 15;89(2):157-62.

PMID:
8697424
13.

Genesis of variant Philadelphia chromosome translocations in chronic myelocytic leukemia.

Naumann S, Decker HJ.

Cancer Genet Cytogenet. 2003 Nov;147(1):18-22.

PMID:
14580766
14.

Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.

Su XY, Wong N, Cao Q, Yu LZ, Niu C, Wickham N, Johnson PJ, Chen Z, Chen SJ.

Cancer Genet Cytogenet. 1999 Jan 1;108(1):6-12.

PMID:
9973917
16.

A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome.

Zagaria A, Anelli L, Albano F, Storlazzi CT, Liso A, Roberti MG, Buquicchio C, Liso V, Rocchi M, Specchia G.

Cancer Genet Cytogenet. 2004 Apr 1;150(1):81-5.

PMID:
15041230
17.

Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.

Morel F, Bris MJ, Herry A, Calvez GL, Marion V, Abgrall JF, Berthou C, Braekeleer MD.

Eur J Haematol. 2003 Apr;70(4):235-9.

PMID:
12656747
18.
19.

Contribution of fluorescence in situ hybridization analyses to the characterization of masked and complex Philadelphia chromosome translocations in chronic myelocytic leukemia.

Morel F, Herry A, Le Bris MJ, Morice P, Bouquard P, Abgrall JF, Berthou C, De Braekeleer M.

Cancer Genet Cytogenet. 2003 Dec;147(2):115-20.

PMID:
14623460
20.

A three way complex translocation (4; 9; 22) in two patients with chronic myelocytic leukemia.

Sheth FJ, Sheth JJ, Verhest A.

J Cancer Res Ther. 2005 Apr-Jun;1(2):108-10.

Supplemental Content

Support Center